Type I and II Endometrial Cancers: Have They Different Risk Factors?
Veronica Wendy Setiawan(University of Southern California), Jennifer A. Doherty(Cancer Prevention Institute of California), Christine M. Friedenreich(University of Calgary), Harvey A. Risch(University of New Haven), Marjorie L. McCullough(American Cancer Society), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Koen Van de Vijver(Cancer Prevention Institute of California), Susan E. McCann(Roswell Park Comprehensive Cancer Center), Catherine Schairer(National Cancer Institute), Xiaolin Liang(Northwest Minzu University), Marc T. Goodman(Cedars-Sinai Medical Center), Carlotta Sacerdote(Cancer Prevention Institute of California), Susan E. Hankinson(University of Massachusetts Amherst), Jennifer Prescott(Cancer Prevention Institute of California), Silvia Polidoro(Cancer Prevention Institute of California), Fulvio Ricceri(Cancer Prevention Institute of California), Robert A. Soslow(Cleveland Clinic), Sara H. Olson(Memorial Sloan Kettering Cancer Center), Yikyung Park(Cancer Prevention Institute of California), Kirsten B. Moysich(American Cancer Society), Yong‐Bing Xiang(Chinese University of Hong Kong), Anthony B. Miller(University of Toronto), Thomas E. Rohan(Albert Einstein College of Medicine), Nicolas Wentzensen(National Cancer Institute), Jo L. Freudenheim(University at Buffalo, State University of New York), Malcolm C. Pike(Kettering University), Kim Robien(Milken Institute), Herbert Yu(Cancer Center of Hawaii), Timothy R. Rebbeck(Dana-Farber Cancer Institute), Montserrat García‐Closas(Institute of Cancer Research), Mia M. Gaudet(Cancer Prevention Institute of California), Anthony M. Magliocco(Cancer Prevention Institute of California), Hannah Yang(Cancer Prevention Institute of California), Xiao‐Ou Shu(Vanderbilt University Medical Center), Alicja Wolk(Karolinska Institutet), Lingeng Lu(Yale Cancer Center), Noel S. Weiss(Cancer Prevention Institute of California), Brian L. Strom(Rutgers, The State University of New Jersey), Niclas Håkansson(Cancer Prevention Institute of California), Radhai Rastogi(Cancer Prevention Institute of California), Laurence N. Kolonel(Cancer Center of Hawaii), Galina Lurie(Cancer Prevention Institute of California), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Rayna K. Matsuno(Cancer Prevention Institute of California), James V. Lacey(Cancer Prevention Institute of California), Pamela J. Thompson(Cancer Prevention Institute of California), Jolanta Lissowska, Brian E. Henderson(Trinity College Dublin), Piet A. van den Brandt(Netherlands Comprehensive Cancer Organisation)
Cited by 833
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Body-Mass Index and Mortality among 1.46 Million White Adults
|New England Journal of Medicine|2010|2.3k